Literature DB >> 28540442

Outcome after brachial plexus injury surgery and impact on quality of life.

Lukas Rasulić1,2, Andrija Savić3, Bojana Živković3, Filip Vitošević4, Mirko Mićović5,3, Vladimir Baščarević5,3, Vladimir Puzović6, Nenad Novaković7, Milan Lepić7, Miroslav Samardžić5,3, Stefan Mandić-Rajčević8.   

Abstract

BACKGROUND: The aim of this study was to investigate outcomes after surgery for brachial plexus injury (BPI), not only motor outcomes but also the quality of life of the patients.
METHODS: We operated on 128 consecutive patients with BPI from 1992 to 2012. We documented the information on the injured nerve, level of injury, type of treatment used, timing of surgery, patient age, and preoperative and postoperative motor deficits. In 69 patients who agreed to participate in a quality of life study, additional assessments included functionality, pain, quality of life, patient satisfaction, and psychosocial health.
RESULTS: Of patients who underwent only exploration and neurolysis, 35.3% showed a good quality of recovery. Patients who underwent nerve reconstruction using nerve grafting showed a better rate of good quality recovery (56.7%), and the results following nerve transfer depended on the type of transfer used. After surgery, 82.6% of patients showed significant improvement, 82.6% were satisfied, and 81.2% responded positively when asked if they would undergo surgery again if they knew the current result beforehand. Overall, 69.6% patients continued working after surgery. The mean DASH disability score was high (58.7) in the study group. Patients who had early surgery showed a consistently higher DASH score. About 76% of patients reported having pain regularly, and 18.8% reported depression or anxiety.
CONCLUSIONS: We consider that it is important to report not only muscle recovery, but also other aspects of recovery.

Entities:  

Keywords:  Disability; Functionality; Satisfaction; Upper extremity nerve injury

Mesh:

Year:  2017        PMID: 28540442     DOI: 10.1007/s00701-017-3205-1

Source DB:  PubMed          Journal:  Acta Neurochir (Wien)        ISSN: 0001-6268            Impact factor:   2.216


  7 in total

1.  Quantifying Real-World Upper-Limb Activity Via Patient-Initiated Movement After Nerve Reconstruction for Upper Brachial Plexus Injury.

Authors:  Brandon W Smith; Kate W-C Chang; Serena J Saake; Lynda J-S Yang; Kevin C Chung; Susan H Brown
Journal:  Neurosurgery       Date:  2019-09-01       Impact factor: 4.654

2.  Indirect Cost of Traumatic Brachial Plexus Injuries in the United States.

Authors:  Thomas S Hong; Andrea Tian; Ryan Sachar; Wilson Z Ray; David M Brogan; Christopher J Dy
Journal:  J Bone Joint Surg Am       Date:  2019-08-21       Impact factor: 5.284

3.  Clinical and functional outcome after different surgical approaches for brachial plexus injuries: Cohort study.

Authors:  Jimmy Kuncoro; Fani Deapsari; Heri Suroto
Journal:  Ann Med Surg (Lond)       Date:  2022-05-10

4.  The effect of a high-quality nursing model employing low-frequency pulse electrical stimulation combined with early systemic functional exercises on the function of the affected limb in brachial plexus injury patients.

Authors:  Xiaoyu Huang; Zongyuan Jiang; Haoran Sun; Bangzhu Xie; Fang Lu; Wenlong Huang; Ting Wang; Haiyan Xiong
Journal:  Am J Transl Res       Date:  2021-05-15       Impact factor: 4.060

5.  Traumatic brachial plexus injury rehabilitation using neuromuscular electrical muscle stimulation in a polytrauma patient.

Authors:  Jessica Anne Rich; Abraham Newell; Timothy Williams
Journal:  BMJ Case Rep       Date:  2019-12-23

6.  Socioeconomic Disparities in Brachial Plexus Surgery: A National Database Analysis.

Authors:  Alexandra Bucknor; Anne Huang; Winona Wu; Aaron Fleishman; Sabine Egeler; Anmol Chattha; Samuel J Lin; Matthew L Iorio
Journal:  Plast Reconstr Surg Glob Open       Date:  2019-02-05

7.  Bionic Upper Limb Reconstruction: A Valuable Alternative in Global Brachial Plexus Avulsion Injuries-A Case Series.

Authors:  Laura A Hruby; Clemens Gstoettner; Agnes Sturma; Stefan Salminger; Johannes A Mayer; Oskar C Aszmann
Journal:  J Clin Med       Date:  2019-12-20       Impact factor: 4.241

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.